Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

18-Fluorodeoxyglucose imaging in oncology.

J A Harolds1

  • 1Integris Baptist Medical Center, Oklahoma City 73112-4481, USA.

The Journal of the Oklahoma State Medical Association
|October 3, 1999
PubMed
Summary

18-Fluorodeoxyglucose (FDG) scans are valuable diagnostic tools for cancer staging. Positron Emission Tomography (PET) or PET/SPECT imaging is essential for these oncologic studies, aiding healthcare providers in patient evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Residents: be aggressive in your own education!

Academic radiology·1998
Same author

Tips for getting a position with an independent private practice radiology group.

Academic radiology·1998
Same author

Correlation of gallbladder ejection fraction with pathologic grade for chronic inflammation.

Southern medical journal·1998
Same author

Technetium-99m-albumin colloid lymphoscintigraphy in postoperative lymphocele.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1996
Same author

Residency evaluations.

Academic radiology·1996
Same author

The radiology resident in difficulty.

Academic radiology·1995

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • 18-Fluorodeoxyglucose (FDG) is a radiopharmaceutical used in diagnostic imaging.
  • Positron Emission Tomography (PET) and hybrid PET/SPECT scanners are required for oncologic studies utilizing FDG.
  • Dissemination of knowledge regarding FDG scan utility and limitations is crucial for healthcare providers.

Purpose of the Study:

  • To describe the application of 18-Fluorodeoxyglucose (FDG) scans in the diagnostic evaluation of cancer patients.
  • To inform healthcare providers about the evolving uses and limitations of FDG scans in oncology.

Main Methods:

  • Utilizing 18-Fluorodeoxyglucose (FDG) as a radiotracer.
  • Employing dedicated Positron Emission Tomography (PET) or hybrid PET/SPECT imaging units for oncologic studies.

Main Results:

  • FDG scans are currently used for staging specific cancers, including non-small cell lung carcinoma, malignant melanoma, Hodgkin's disease, non-Hodgkin's lymphoma, colorectal carcinoma, and head and neck carcinoma.
  • The availability of PET and PET/SPECT scanners facilitates these diagnostic evaluations.

Conclusions:

  • FDG scans represent an important diagnostic modality in oncology.
  • Effective utilization of FDG scans requires understanding their benefits and limitations in various cancer types.

Related Experiment Videos